Hypertension Trial, Recruiting (NCT06317467)

Hypertension Trial, Recruiting NCT06317467 Sponsor: IRCCS Burlo Garofolo Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT06317467 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women who have a normal, healthy pregnancy and agree to sign a consent form and return to the maternity hospital for a follow-up visit 40 days after giving birth.
Women who have been diagnosed with pre-eclampsia, a condition where high blood pressure develops after 20 weeks of pregnancy along with protein found in the urine.
Women who have been diagnosed with lupus (SLE), antiphospholipid syndrome (APS), or autoimmune thyroid disease, and who attend a fertility or rheumatology department at the University Medical Centre Ljubljana in Slovenia.

Who may not be able to join:

Women who are under 18 years of age.
Women who have a blood-transmitted viral or bacterial infection.
Women from whom consent to participate cannot be obtained.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +39.040.5588652

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06317467

Sponsor: IRCCS Burlo Garofolo

Phase: Not Applicable

Status: Recruiting

Condition: Hypertension

Trial contact: +39.040.5588652

More information: https://clinicaltrials.gov/study/NCT06317467

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women who have a normal, healthy pregnancy and agree to sign a consent form and return to the maternity hospital for a follow-up visit 40 days after giving birth.
Women who have been diagnosed with pre-eclampsia, a condition where high blood pressure develops after 20 weeks of pregnancy along with protein found in the urine.
Women who have been diagnosed with lupus (SLE), antiphospholipid syndrome (APS), or autoimmune thyroid disease, and who attend a fertility or rheumatology department at the University Medical Centre Ljubljana in Slovenia.

Who may not be able to join:

Women who are under 18 years of age.
Women who have a blood-transmitted viral or bacterial infection.
Women from whom consent to participate cannot be obtained.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

IRCCS Burlo Garofolo

Registry

ClinicalTrials.gov

Start date

13 September 2023

Est. completion

1 December 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Between groups difference in percentage of anti-gC1q compared to the total anti-C1q autoantibodies; Between groups difference in percentage of anti-cC1q compared to the total anti-C1q autoantibodies; Between groups difference in percentage of anti-gC1q compared to the total anti-C1q autoantibodies; Between groups difference in percentage of anti-cC1q compared to the total anti-C1q autoantibodies; Between groups difference in percentage of anti-gC1q compared to the total anti-C1q autoantibodies; Between groups difference in percentage of anti-cC1q compared to the total anti-C1q autoantibodies;...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov